NorthWest Biotherapeutics Inc (NWBO)

[Gus McCrae]

I hear you Gandalf. But my question to you is this: if they really think they have a universal cure for cancer, why did they tell us a couple weeks ago that they only have the capacity to treat up to 500 patients per year and that they were planning to use their additional space for 3rd party contract manufacturing? They had TLD when they issued that press release, and yet, as positive as it is that they are close to being ready to apply to the U.K for certification of the facility, it doesn't support a conclusion that DCVAX-L is about to be rolled out for all GBM patients, much less other indications. In my opinion, that press release was largely an effort to set some expectations about valuation going forward. I don't see the point of the detail they gave about the potential for annual supply and how they are going to use the extra capacity otherwise.